• 제목/요약/키워드: drug supply

검색결과 101건 처리시간 0.021초

Marine-Derived Pharmaceuticals - Challenges and Opportunities

  • Lindequist, Ulrike
    • Biomolecules & Therapeutics
    • /
    • 제24권6호
    • /
    • pp.561-571
    • /
    • 2016
  • Marine biosphere is the largest one of the earth and harbors an enormous number of different organisms. Living conditions differ fundamentally from those in terrestrial environment. The production of specific secondary metabolites is an important adaption mechanism of marine organisms to survive in the sea. These metabolites possess biological activities which make them interesting as possible drugs for human. The review presents sources, chemistry, production and pharmacology of FDA approved marine derived pharmaceuticals arranged according to their therapeutic indication. Four of the presently seven approved drugs are used for the treatment of cancer. Each another one is applicated for treatment of viral diseases, chronic pain and to lower triglyceride level in blood. Some other products are of interest in diagnostic and as experimental tools. Besides, this article describes challenges in drug development from marine sources, especially the supply problem.

Isolation and Identification of Taxol, an Anticancer Drug from Phyllosticta melochiae Yates, an Endophytic Fungus of Melochia corchorifolia L.

  • Kumaran, Rangarajulu Senthil;Muthumary, Johnpaul;Hur, Byung-Ki
    • Food Science and Biotechnology
    • /
    • 제17권6호
    • /
    • pp.1246-1253
    • /
    • 2008
  • Phyllosticta melochiae, an endophytic fungus isolated from the healthy leaves of Melochia corchorifolia, was screened for the production of an anticancer drug, taxol on modified liquid medium and potato dextrose broth medium in culture for the first time. The presence of taxol was confirmed by spectroscopic and chromatographic methods of analysis. The amount of taxol produced by this fungus was quantified by high performance liquid chromatography. The maximum amount of fungal taxol production was recorded as $274{\mu}g/L$. The production rate was increased to $5.5{\times}1,000$ fold than that found in the culture broth of earlier reported fungus, Taxomyces andreanae. The fungal taxol extracted also showed a strong cytotoxic activity in the in vitro culture of tested human cancer cells by apoptotic assay. The results designate that the fungal endophyte, P. melochiae is an excellent candidate for an alternate source of taxol supply and can serve as a potential species for genetic engineering to enhance the production of taxol to a higher level.

Molecular cloning of a cytochrome $P_{450}$-dependent monooxygenase cDNA from Panax ginseng C.A. Meyer

  • Park, Su-Jung;Jung, Da-Woon;Sung, Chung-Ki
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.376.2-377
    • /
    • 2002
  • Some of the dammarane-type saponins. ginsenosides of Panax ginseng C.A. Meyer (Araliaceae) are now well established as a potent chemotherapeutic agent against a wide variety of aliments. Its various pharmacological and biological activities have been thoroughly reviewed (S. Shibata, 2001). The limited supply of the drug from the original source. the hairy root of the Panax ginseng promoted intense efforts to develop alternate sources and means of production. (omitted)

  • PDF

과실류 및 채소류 중 아황산염류 함유량 조사연구 (A Study on Contents of Sulfites in Fruits and Vegetables)

  • 문태정;김기준;박성민;김현정;박종진;강현각;정상미;이미영;구자항;임지순
    • 한국식품저장유통학회지
    • /
    • 제13권4호
    • /
    • pp.432-437
    • /
    • 2006
  • 2005년 3월부터 10월까지 과채류 152건을 대상으로 아황산염류의 자연함유량과 인위적인 사용실태를 비교하기 위하여 모니어-윌리암스 변법을 사용하여 이산화황의 함유량을 분석하였다. 가공하지 않은 14품목 42건에 대한 이산화황 분석결과 평균검출범위는 $0.00\sim9.46mg/kg$이었으며, 각 품목별 평균으로는 무가 8.97 mg/kg으로 가장 높았고 양파가 8.04 mg/kg 순으로 조사되었다. 가공한 23품목 110 건에 대한 이산화황 평균분석결과 검출범위는 $0.00\sim1,828.59mg/kg$이었으며, 각 품목별 평균으로는 박고지가 1,064.61 mg/kg으로 가장 높았고, 건살구 869.62 mg/kg, 곶감 64.11 mg/kg, 무말랭이 29.00 mg/kg, 호박고지 17.63 mg/kg의 순으로 검출되었으며 그 외는 10.00 mg/kg 미만으로 모두 기준이내이었다. 수입산의 평균검출범위는 $0.00\sim1,828.59mg/kg$이었으며 국내산은 $0.00\sim63.58mg/kg$이 검출되어 중국산 박고지와 터키산 건살구를 제외하고는 유사한 수준으로 조사되었다. 위의 조사결과 안전한 먹거리 제공을 위해서 황함유식품 및 아황산염류의 사용기준이 설정된 식품에 대하여 지속적이고 체계적인 모니터링을 통한 자연함유량 자료구축으로 정확한 판단 근거를 제시해야 할 것으로 판단된다.

졸피뎀의 체계적 관리 방안 연구 (A Study on the Systematic Management of Zolpidem)

  • 정수철
    • 한국콘텐츠학회논문지
    • /
    • 제20권2호
    • /
    • pp.462-471
    • /
    • 2020
  • 일반적으로 수면제로 사용되는 졸피뎀은 신경 억제 물질을 증가시키기 위해 GABA 수용체에 결합한다. 실제 졸피뎀을 4주 이상 연속으로 복용하는 경우는 많이 있다. 현재 한국에서 시행되고 있는 의약품 사용평가(DUR)은 졸피뎀의 사용 패턴을 확인할 수 있다. 수면제인 졸피뎀의 과다 사용을 예방 할 필요가 있다. 본 연구는 2019년 5월 10일부터 2019년 5월 15일까지 진행되었다. 검색된 총 125,197건의 문서 중 1차 및 2차 선별을 실시하여 진행하였다. 졸피뎀 과다 사용과 직접적인 관련이 있는 최종 254개의 문헌 사례를 선정하였다. 체계적인 문헌 연구를 통해 졸피뎀의 과다 사용을 예방 할 수 있는 방안을 모색하고자 하였다. 연구대상 선별과정에서 연구의 비뚤림 효과를 최소화 하였다. 졸피뎀의 과다 사용은 심각했으며 사용량이 계속 증가하는 추세였다. 졸피뎀을 이용한 범죄도 증가하고 있었다. 졸피뎀은 마약류 통합 관리 시스템과 의약품 사용평가를 통해 관리 될 수 있다고 연구되었다. 졸피뎀의 사용을 줄이기 위해서는 마약류 통합관리 시스템과 과다 사용자 교육을 통한 수요와 공급을 동시에 억제할 필요가 있다.

An In sight into Novel Drug Delivery System: In Situ Gels

  • Bashir, Rabiah;Maqbool, Mudasir;Ara, Irfat;Zehravi, Mehrukh
    • 셀메드
    • /
    • 제11권1호
    • /
    • pp.6.1-6.7
    • /
    • 2021
  • In situ gelling devices, as they enter the body, are dosage forms in the shape of the sol but turn into gel types under physiological circumstances. Transition from sol to gel is contingent on one or a mixture of diverse stimuli, such as transition of pH control of temperature, irradiation by UV, by the occurrence of certain ions or molecules. Such characteristic features may be commonly employed in drug delivery systems for the production of bioactive molecules for continuous delivery vehicles. The technique of in situ gelling has been shown to be impactful in enhancing the potency of local or systemic drugs supplied by non-parenteral pathways, increasing their period of residence at the absorption site. Formulation efficacy is further improved with the use of mucoadhesive agents or the use of polymers with both in situ gelling properties and the ability to bind with the mucosa/mucus. The most popular and common approach in recent years has provided by the use of polymers with different in situ gelation mechanisms for synergistic action between polymers in the same formulation. In situ gelling medicine systems in recent decades have received considerable interest. Until administration, it is in a sol-zone and is able to form gels in response to various endogenous factors, for e.g elevated temperature, pH changes and ions. Such systems can be used in various ways for local or systemic supply of drugs and successfully also as vehicles for drug-induced nano- and micro-particles. In this review we will discuss about various aspects about use of these in situ gels as novel drug delivery systems.

식품의약품안전처의 위생점검표에 의한 육아지원기관 급식소 평가 및 개선대책 (Assessment and Corrective Measures of Child-care Foodservices by Sanitary Inspection Checklist Suggested by Korea Food and Drug Administration)

  • 안수정;문혜경
    • 대한영양사협회학술지
    • /
    • 제21권3호
    • /
    • pp.227-240
    • /
    • 2015
  • The purpose of this study was to assess the hygiene status of 145 child-care foodservices, which were newly registered in the Center for the Children's Foodservice Management (CCFSM) in Changwon, Gyeongnam. Sanitary inspection checklist (40 food safety items) of Korea Food and Drug Administration (KFDA) was used by the CCFSM in Changwon, Gyeongnam. Average score from the total safety items in 145 child-care foodservices was 21.41 points out of 40 points. Score gaps between the lower group (71 foodservices, 13.92 points) and higher group (74 foodservices, 28.61 points) showed a significant difference (P<0.001). The top five priorities of sanitary measures needing corrective actions for child-care foodservices were as follows: 'provide hand washing and sanitizing tools, and supply manuals on how to wash hands properly', 'supply record form for access/inspection', 'conduct education for cooks on standards in the selection of sanitizer for raw vegetables and proper methods to wash and sanitize raw vegetables', 'provide a refrigerator and a freezer with installed thermometers and temperature record monitoring logs', 'encourage separation of contamination operating zone and clean zone or conduct training for cooks on ways to prevent cross-contamination by performing work separately by the hour'. For the higher group, most were national/public facilities (83.3%), whereas in the lower group, private facilities (62.1%) were more common than national/public ones (37.9%). Therefore, a significant difference (P<0.001) was detected in the two groups. These private facilities should be supported.

환경유래 식품오염물질의 범부처 통합 저감화 플랫폼 설계 (Design of Integrated Reduction Platform for Food Contaminants Derived from the Environment through Interagency Collaboration in Korea)

  • 고아라;허지영;강영운;강길진;정명섭;이헌주
    • 한국환경보건학회지
    • /
    • 제43권4호
    • /
    • pp.307-313
    • /
    • 2017
  • Objectives: Chemicals derived from various environment media contaminates food across the food supply chain. In Korea, levels of contaminants in food have been sporadically measured by monitoring programs of different government agencies. There is difficulty with data compilation and integrated analysis across media. Therefore, the aim of this study was to propose an overall integrated database and analytical platform design for the 'ECO-FOOD NET (Environmental COntaminant reduction platform for FOOD through an interagency collaboration NETwork)', a tool to support the reduction of environmental contaminants in food. Methods: We developed a new data structure and standardized protocols for the compilation of integrated data. In addition, we conducted subject-oriented logical and physical relational database modeling and created the architecture design of the platform. Results: We established a standardized code system related to exposure media and route, analysis method and food matrix. In addition, we designed the seven software modules of 'About the System', 'Introduction to Interagency Work', 'Media-Chemicals Profiles', 'Method Bank', 'Monitoring Data Base', 'Integrated Media Analysis', and 'Risk-Benefit Analysis'. Conclusions: This study will contribute to decision-making as a tool for executing risk management, such as sustainable reduction policies of contaminants in food.

혈관신생 분자핵의학 영상 (Molecular Nuclear imaging of Angiogenesis)

  • 이경한
    • 대한핵의학회지
    • /
    • 제38권2호
    • /
    • pp.171-174
    • /
    • 2004
  • Angiogenesis, the formation of new capillaries from existing vessels, increases oxygenation and nutrient supply to ischemic tissue and allows tumor growth and metastasis. As such, angiogenesis targeting provides a novel approach for cancer treatment with easier drug delivery and less drug resistance. Therapeutic anti-angiogenesis has shown impressive effects in animal tumor models and are now entering clinical trials. However, the successful clinical introduction of this new therapeutic approach requires diagnostic tools that can reliably measure angiogenesis in a noninvasive and repetitive manner. Molecular imaging is emerging as an exciting new discipline that deals with imaging of disease on a cellular or genetic level. Angiogenesis imaging is an important area for molecular imaging research, and the use of radiotracers offers a particularly promising technique for its development. While current perfusion and metabolism radiotracers can provide useful information related to tissue vascularity, recent endeavors are focused on the development of novel radioprobes that specifically and directly target angiogenic vessels. Presently available proges include RGD sequence containing peptides that target ${\alpha}_v\;{\beta}_3$ integrin, endothelial growth factors such as VEGF or FGF, metalloptoteinase inhibitors, and specific antiangiogenic drugs. It is now clear that nuclear medicine techniques have a remarkable potential for angiogenesis imaging, and efforts are currently continuing to develop new radioprobes with superior imaging properties. With future identification of novel targets, design of better probes, and improvements in instrumentation, radiotracer angiogenesis imaging promises to play an increasingly important role in the diagnostic evaluation and treatment of cancer and other angiogenesis related diseases.

주요국의 제네릭 의약품 활성화 정책 고찰과 시사점 (Lessons from Generic Promotion Policies in Other Countries)

  • 김동숙;배승진;장선미
    • 보건행정학회지
    • /
    • 제23권3호
    • /
    • pp.210-223
    • /
    • 2013
  • Backgrounds: Escalating pharmaceutical expenditure has threatened the sustainability of National Health Insurance system in Korea. Generic medicines allow patients to access safe, effective, high-quality medicines at low cost, thus insurers could achieve significant financial savings by promotion of generics, if they are priced much lower than the originator. The purpose of this study was to review generic pricing as well as promotion policies in other countries and assess the implication of those policies. Methods: We reviewed the main measures adopted by the developed countries such as Austria, Belgium, Denmark, Finland, France, Germany, Italy, Japan, Netherlands, Norway, Sweden, United Kingdom, especially in countries where governments are the largest third-party payers or insurance finance resource is the national health insurance. Results: The foreign countries's experience with generic medicine policy shows that demand-side policies such as physician budgets, international nonproprietary name prescribing, generics substitution, patients co-payment as well as supply-side policies relating to pricing and reimbursement seems to play a critical role in developing the generic medicines market. Conclusion: Various strategy should be implemented to promote generic drug use.